TRI Exercises Option to Advance Acquisition of Stabl-Im
Filed with ASX · · 2 pages · English
Story so far
Earlier from TrivarX
- September 2025 Quarterly Activities Report and Appendix 4C
- US-veteran mental health trial patient recruitment complete
- Acquisition of Stabl-Im technology and Private Placement
- Reinstatement to Official Quotation
- Extension of Trading Suspension
Later from TrivarX
- Positive results from US-veteran mental health trial
- December 2025 Quarterly Activities Report and Appendix 4C
- Appendix 4D & Half-Year Financial Report to 31 December 2025
- Dr Danielle Meyrick appointed as CEO
- March 2026 Quarterly Activities Report and Appendix 4C
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX